Skip to Main Content

Author Details

Louis Lacombe
CHU de Quebec-Universite Laval
1994
152
40
PMIDPaper TitleJournal TitlePublished Year
37931285Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBC.Can Urol Assoc J2024
36343786UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.Cancer Lett2023
37787025Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial.Cancer Med2023
37190147Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.Cancers (Basel)2023
37086156Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.Mol Oncol2023
37451291Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.Lancet Oncol2023
36986098Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA).Nutrients2023
37435060High infiltration of CD209<sup>+</sup> dendritic cells and CD163<sup>+</sup> macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.Front Immunol2023
36373402Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer.J Urol2023
36347965Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer.Br J Cancer2023
34259197Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer.Asian J Androl2022
35598879Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.Mol Metab2022
35528461Sex steroid modulation of macrophages within the prostate tumor microenvironment.Am J Clin Exp Urol2022
35621285Perception and satisfaction of patients after telemedicine urology consultations: A matched analysis with physicians' perspective.Can Urol Assoc J2022
36272848Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancer.Urol Oncol2022
36102111Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level.J Urol2022
35954173Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients.Cells2022
35977756Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.J Immunother Cancer2022
35063205Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy.Clin Nutr ESPEN2022
32676741Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.World J Urol2021
33828256Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression.Br J Cancer2021
33750523<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy.Can Urol Assoc J2021
35099374Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.Can Urol Assoc J2021
35128221Double inferior vena cava systems during retroperitoneal surgery: Description of a systematic approach to a rare and challenging anatomic variant.J Vasc Surg Cases Innov Tech2021
33938798Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.Can Urol Assoc J2021
32656670Achieving the "trifecta" with open versus minimally invasive partial nephrectomy.World J Urol2021
33275552A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicine.Can Urol Assoc J2020
31845837Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy.J Urol2020
31727674Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.Drug Metab Dispos2020
32047296Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.Br J Cancer2020
29623528A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.Pathol Oncol Res2019
30113732Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.BJU Int2019
30136199The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.World J Urol2019
31265453Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.PLoS Med2019
31594737Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?Clin Genitourin Cancer2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30733309A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer.Cancer Epidemiol Biomarkers Prev2019
30762265Psychosocial adjustment to a prostate cancer diagnosis in a cohort of radical prostatectomy patients in Quebec, Canada.Psychooncology2019
30819787Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.Drug Metab Dispos2019
30871997Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.Urol Oncol2019
30673630Discordance between testosterone measurement methods in castrated prostate cancer patients.Endocr Connect2019
29609897Increased Prostate Cancer Glucose Metabolism Detected by <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration.Eur Urol Focus2019
28972698Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.BJU Int2018
29880461Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer.Urol Oncol2018
30200929The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.BMC Urol2018
29688881Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma.Can Urol Assoc J2018
28065393Quality indicators in the management of bladder cancer: A modified Delphi study.Urol Oncol2017
28215848Erratum to "The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System" [Urol Oncol 34(11) (2016) 486.e1-486.e7].Urol Oncol2017
29106362Preoperative nutritional factors and outcomes after radical cystectomy: A narrative review.Can Urol Assoc J2017
  • 1 - 50 of 152

Recommended Authors

Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 13
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 5
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 8
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 18
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 2
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 24
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 17
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 18
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 13
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 3
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 14
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 2
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 9
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 12
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 5
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 17
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 8
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 18
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 24
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 11
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 12
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 15
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 33
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 10
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 22
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 12

Collaborators

Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 99
Fred Saad
University of Montreal Health Center
Co-authored papers 32
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 30
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 24
Joseph L Chin
University of Western Ontario
Co-authored papers 24
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 22
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 20
Simone Chevalier
McGill University Health Centre, McGill University
Co-authored papers 13
Fran??ois Meyer
Laval University
Co-authored papers 10
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 9
Neil E Fleshner
University of Toronto
Co-authored papers 8
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 8
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 7
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 7
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 7
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 6
David Robert Siemens
Queen's University
Co-authored papers 6
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 6
Robert G Bristow
University of Toronto
Co-authored papers 6
Martin E Gleave
University of British Columbia
Co-authored papers 6
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers 5
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 5
Paul C Boutros
University of California los angeles
Co-authored papers 5
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 4
Julie Livingstone
University of California los angeles
Co-authored papers 4
Eleonora Scarlata
Research Institute of the McGill University Health Center (RI-MUHC)
Co-authored papers 4
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 3
Release 1.2